Axitinib is a selective inhibitor of vascular endothelial growth factor (VEGFR) receptors. It is indicated in the treatment of renal cell cancer when other alternative therapies have failed. Let's learn about the uses and notes when using Axitinib through the article below.

Ultrasound in the diagnosis of renal cell cancer can observe the location and size of renal cell cancer and treat it promptly when the tumor has no clinical symptoms.

Renal cell carcinoma is one of the most common types of urinary tract cancer, often seen in people over the age of 50. This is a dangerous cancer that can cause serious complications for the patient, even lead to death if not treated promptly.